0x

guest@0xbase ~$ read-only mode. Posting requires EU location.

Showing articles whose micro-themes are very close to: #WHO R&D timeline
  1. WHO: Bundibugyo Ebola vaccine months away from human trials (nbcnews.com) | 20d ago
  2. WHO Technical Advisory Group recommends BDBV-specific vaccines as preferred, considers Ervebo for post-exposure use in Bundibugyo outbreak (iris.who.int) | 15d ago
  3. Search Begins for Vaccine as Bundibugyo Ebola Deaths Rise (pharmaphorum.com) | 19d ago
  4. Ebola Vaccines Exist, But Not for Bundibugyo Strain in Current Uganda Outbreak (scientificamerican.com) | 17d ago
  5. Overview of experimental vaccines and treatments for Bundibugyo Ebola in DRC outbreak (cnbcafrica.com) | 11d ago
  6. WHO recommends Ebola treatments and vaccines be tested only in clinical trials (ca.news.yahoo.com) | 12d ago
  7. Safety, Tolerability, Pharmacokinetics, and Immunogenicity of mAb114 (pmc.ncbi.nlm.nih.gov) | 17d ago
  8. WHO Summarizes Key Facts and Response Protocols for Ebola Virus Disease (youtube.com) | 14d ago
  9. WHO Issues Updated Guideline on Therapeutics for Ebola Virus Disease (iris.who.int) | 14d ago
  10. Gavi statement on the Ebola disease outbreak in Democratic Republic of the Congo and Uganda (gavi.org) | 18d ago
  11. Coalition for Epidemic Preparedness Innovations (CEPI) updates Ebola vaccine development progress (youtube.com) | 14d ago
  12. WHO prioritizes Regeneron's maftivimab for Bundibugyo ebolavirus trials (simplywall.st) | 9d ago
  13. Ebola Virus Disease Vaccines – WHO Q&A (who.int) | 17d ago
  14. Factbox: Bundibugyo Ebola vaccines and treatments in development (devdiscourse.com) | 18d ago
  15. WHO Advisory Group Recommends Maftivimab for Clinical Trials in Bundibugyo Ebola Outbreak (rttnews.com) | 11d ago
Showing page 1 of 1 (15 total results)
← Prev Next →